286 related articles for article (PubMed ID: 30039416)
21. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
22. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
23. Application of Virtual Screening Approaches for the Identification of Small Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.
Luise C; Robaa D
Methods Mol Biol; 2018; 1824():347-370. PubMed ID: 30039418
[TBL] [Abstract][Full Text] [Related]
24. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling.
Vuorinen A; Schuster D
Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773
[TBL] [Abstract][Full Text] [Related]
25. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
26. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
[TBL] [Abstract][Full Text] [Related]
27. Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase.
Bhojwani HR; Joshi UJ
Curr Comput Aided Drug Des; 2017; 13(3):186-207. PubMed ID: 27981900
[TBL] [Abstract][Full Text] [Related]
28. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
29. Enhancing Virtual Screening Performance of Protein Kinases with Molecular Dynamics Simulations.
Offutt TL; Swift RV; Amaro RE
J Chem Inf Model; 2016 Oct; 56(10):1923-1935. PubMed ID: 27662181
[TBL] [Abstract][Full Text] [Related]
30. Pharmacophore modeling, molecular docking and molecular dynamics simulations toward identifying lead compounds for Chk1.
Li Y; Peng J; Zhou Y; Li P; Li Y; Liu X; Siddique AN; Zhang L; Zuo Z
Comput Biol Chem; 2018 Oct; 76():53-60. PubMed ID: 29940486
[TBL] [Abstract][Full Text] [Related]
31. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.
Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U
J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963
[TBL] [Abstract][Full Text] [Related]
32. Comparing pharmacophore models derived from crystal structures and from molecular dynamics simulations.
Wieder M; Perricone U; Seidel T; Boresch S; Langer T
Monatsh Chem; 2016; 147():553-563. PubMed ID: 27069282
[TBL] [Abstract][Full Text] [Related]
33. Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluation.
Rajamanikandan S; Jeyakanthan J; Srinivasan P
Microb Pathog; 2017 Feb; 103():40-56. PubMed ID: 27939874
[TBL] [Abstract][Full Text] [Related]
34. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
35. Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening.
Pentikäinen OT; Postila PA
Methods Mol Biol; 2021; 2266():141-154. PubMed ID: 33759125
[TBL] [Abstract][Full Text] [Related]
36. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Cross JB
Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
[TBL] [Abstract][Full Text] [Related]
37. Emerging methods for ensemble-based virtual screening.
Amaro RE; Li WW
Curr Top Med Chem; 2010; 10(1):3-13. PubMed ID: 19929833
[TBL] [Abstract][Full Text] [Related]
38. Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.
Gioia D; Bertazzo M; Recanatini M; Masetti M; Cavalli A
Molecules; 2017 Nov; 22(11):. PubMed ID: 29165360
[TBL] [Abstract][Full Text] [Related]
39. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
Sengupta S; Roy D; Bandyopadhyay S
J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
[TBL] [Abstract][Full Text] [Related]
40. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
Scarpino A; Ferenczy GG; Keserű GM
Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
